A compound could reduce cataratc eye disease that leads to loss of vision. The magazine Sciencie reported that the product reduces the cloud associated with cataracts, making it a potential treatment for the disease.
This condition affects more than 20 million people worldwide and is the most common cause of blindness. In many cases it can be treated with surgery, but that option leaves out the people of impoverished countries.
Cataracts occur when proteins that are located in the lens, called crystal, are damaged, incorrectly folded inside the eye and become insoluble masses.
Specifically, αA-crystallin (CRYAA) and αB-crystal (CRYAB), are the crystal proteins responsible for the dissolution of other proteins and favoring the formation of age-related cataracts. eye disease that leads to loss of vision.
Cristalino con problemas por catartas. Foto: Infomedic.com.